Taken together, we speculate that the dysregulation of p53 expression brought by the interaction between HCC tumour cells and HSC might lead to downregulation of miRNA-22 expression and galectin-1 overexpression in Ca-HSCs. This evidence concerns the gene TP53 and neoplasm.